With a background of 10 years in venom research, BioConus is specialised in extracting pure venoms from live marine cone snails. * www.bioconus.com * BioConus offers lyophilised venoms from 4 different Conus species: • Conus textile • Conus victoriae • Conus imperialis • Conus striatus Cone snail venoms are natural libraries composed of hundreds of bioactive compounds, also called conopeptides. Conopeptides are small peptides (10-30 amino acids) with selectivity and high-affinity properties for many human receptors and may be used in pharmacological research (especially ion channels), for drug discovery screening and as a potential therapeutic itself. Over the last decade, several conopeptides have been identified with therapeutic potential for: • neurodegenerative diseases, • cardiovascular diseases, • cancer, • pain and inflammation.
| Website | http://www.bioconus.com |
| Revenue | $3 million |
| Employees | 1 (0 on RocketReach) |
| Address | 126 Cope Street, Waterloo, New South Wales 2017, AU |
| Phone | +61 1800 062 088 |
| Fax | +61 2 9698 1022 |
| Technologies |
HTML
,
PHP
,
Twitter
+18 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Venom Research, Toxin Research, Bioactive Compounds, Pharmaceutical Research, Drug Discovery, Biotechnology |
| Competitors | Roche, Merck & Co., Inc., Sanofi, GSK, Novo Nordisk, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Lilly India +40 more (view full list) |
Looking for a particular BioConus employee's phone or email?
The BioConus annual revenue was $3 million in 2026.
BioConus is based in Waterloo, New South Wales.